All News
Rutgers Health researchers will enroll primary or secondary progressive multiple sclerosis (p-MS) patients to see if an engineered immune cell therapy can halt the progression of the autoimmune disease.
Check out some of Rutgers' novel courses for Fall 2024 – many of which are open to all students – tackling global challenges and developing skills to be successful at Rutgers and beyond.
